COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 2891: Articles 28901-28910  | Next

Impact of virus testing on COVID-19 case fatality rate: estimate using a fixed-effects model
Terriau, A., Albertini, J., Poirier, A., LE BASTARD, Q.
10.1101/2020.04.26.20080531 — Posted: 2020-05-01
MODELLING OF COVID-19 OUTBREAK INDICATORS IN CHINA BETWEEN JANUARY AND APRIL
Celik, S., Ankarali, H., Pasin, O.
10.1101/2020.04.26.20080465 — Posted: 2020-05-01
Shedding of infectious SARS-CoV-2 in symptomatic neonates, children and adolescents
L'Huillier, A. G., Torriani, G., Pigny, F., Kaiser, L., Eckerle, I.
10.1101/2020.04.27.20076778 — Posted: 2020-05-01
High frequency of SARS-CoV-2 RNAemia and association with severe disease
Hogan, C. A., Stevens, B., Sahoo, M. K., Huang, C., Garamani, N., Gombar, S., Yamamoto, F., Murugesan, K., Kurzer, J., Zehnder, J., Pinsky, B. A.
10.1101/2020.04.26.20080101 — Posted: 2020-05-01
Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study.
Doi, A., Iwata, K., Kuroda, H., Hasuike, T., Nasu, S., Kanda, A., Nagao, T., Nishioka, H., Tomii, K., Morimoto, T., Kihara, Y.
10.1101/2020.04.26.20079822 — Posted: 2020-05-01 Discussion: Onsite
COVID-19 in healthcare workers in three hospitals in the South of the Netherlands, March 2020
Sikkema, R. S., Pas, S., Nieuwenhuijse, D. F., O'Toole, A., Verweij, J., van der Linden, A., Chestakova, I., Schapendonk, C., Pronk, M. R., Lexmond, P., Bestebroer, T., Overmars, R. J., van Nieuwkoop, S., van den Bijllaardt, W., Bentvelsen, R. G., van Rijen, M. M. L., Buiting, A. G. M., van Oudheusden, A. J. G., Diederen, B. M., Bergmans, A. M. C., van der Eijk, A., Molenkamp, R., Rambaut, A., Timen, A., Kluytmans, J. A. J. W., Oude Munnink, B. B., Kluytmans, M., Koopmans, M. P. G.
10.1101/2020.04.26.20079418 — Posted: 2020-05-01
Projection of hospitalization by COVID-19 in Brazilfollowing different social distances policies
Silva, H. M., Pereira, R. S., Gritz, R. d. A., Simoes, A., Porto, F. A.
10.1101/2020.04.26.20080143 — Posted: 2020-05-01
How the COVID-19 pandemic is favoring the adoption of digital technologies in healthcare: a rapid literature review
Golinelli, D., Boetto, E., Carullo, G., Landini, M. P., Fantini, M. P.
10.1101/2020.04.26.20080341 — Posted: 2020-05-01
Modeling serological testing to inform relaxation of social distancing for COVID-19 control
Kraay, A. N. M., Nelson, K., Zhao, C., Weitz, J. S., Lopman, B. A.
10.1101/2020.04.24.20078576 — Posted: 2020-05-01
Racial, Economic and Health Inequality and COVID-19 Infection in the United States
Abedi, V., Olulana, O., Avula, V., Chaudhary, D., Khan, A., Shahjouei, S., Li, J., Zand, R.
10.1101/2020.04.26.20079756 — Posted: 2020-05-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).